Finerenone - Pharmacy Freak

Mechanism of Action of Kerendia (Finerenone)

June 17, 2026 Harsh Singh Rajput

Introduction Kerendia is the brand name for finerenone, a non-steroidal selective mineralocorticoid receptor antagonist (MRA) used to reduce the risk of chronic kidney disease (CKD) progression and cardiovascular complications in adults with chronic kidney disease associated with type 2 diabetes mellitus. Unlike older steroidal MRAs such as spironolactone and eplerenone, finerenone has a unique non-steroidal … Read more

Mechanism of Action of Finerenone (Kerendia)

July 4, 2025July 1, 2025 Pharmacy Freak Editorial Team Harsh Singh Rajput

Introduction Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist (MRA) approved for reducing the risk of cardiovascular and renal events in adults with chronic kidney disease (CKD) associated with type 2 diabetes mellitus (T2DM). Unlike steroidal MRAs such as spironolactone, finerenone offers greater mineralocorticoid receptor selectivity, minimizing off-target hormonal effects. Step-by-Step Mechanism of Action Pharmacokinetic … Read more